Psoriasis Clinical Trials

Find Psoriasis Clinical Trials Near You

Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris and Its Relation to Pathogenesis and Risk of the Disease

Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Observational
SUMMARY

Psoriasis is a common immune-mediated inflammatory skin disease affecting at least 100 million individuals worldwide. In Egypt, the prevalence of psoriasis ranges between 0.19% and 3% of the Egyptian people. It is associated with poor quality of life, reduced life expectancy and multimorbidity including psoriatic arthritis, obesity and cardiovascular disease. Vaspin (VASP, SERPIN 12) is a recently discovered adipokine that has been isolated from the visceral adipose tissue of a rat model of type 2 diabetes. It is coded by the gene SERPNA12 located on the long arm of chromosome 14q32.13 and consists of six exons and five introns.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: t
View:

• Newly diagnosed cases or stopped treatment of at least 6 months of psoriasis patients.

• Pateints with any age and gender.

Locations
Other Locations
Egypt
Aswan University Hospital
RECRUITING
Aswān
Contact Information
Primary
Ola Mahmoud Samy Mohamed, MSC
olaelqousy@gmail.com
+201025592922
Backup
Mahmoud Ahmed Ali, Lecturer
dr.mahmoudali@aswu.edu.eg
+201002364902
Time Frame
Start Date: 2025-08-10
Estimated Completion Date: 2026-08-20
Participants
Target number of participants: 60
Treatments
Group A: Psoriasis Patients
About 30 patients suffering from Psoriasis Vulgaris will subject to vaspin gene polymorphism measure and Assessment of the disease severity will be performed by using Psoriasis area and severity index score (PASI score) for all patients.
Group B: Control Group
About 30 healthy participants will share as A control Group
Sponsors
Leads: Aswan University

This content was sourced from clinicaltrials.gov